MTIX

Micro Therapeutics (MTIX)

Micro Therapeutics (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MTIX

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2005/12/09	01 : 01	PR Newswire (US)	ev3 Inc. Announces Expected Closing Date for Acquisition of Public Minority Stake in Micro Therapeutics, Inc.	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/11/14	23 : 11	PR Newswire (US)	ev3 Inc. and Micro Therapeutics, Inc. Announce Merger Agreement	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/10/27	22 : 01	PR Newswire (US)	Micro Therapeutics Reports 72% Increase in 2005 Third Quarter Net Sales	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/10/27	22 : 00	PR Newswire (US)	ev3 Inc. Reports Third Quarter Financial Results	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/10/21	23 : 00	PR Newswire (US)	ev3 and Micro Therapeutics to Report 2005 Third-Quarter Financial Results and Host Joint Conference Call on October 27, 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/10/10	23 : 30	PR Newswire (US)	ev3 Inc. Proposes to Acquire Public Minority Stake in Micro Therapeutics, Inc.	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/10/10	22 : 30	PR Newswire (US)	Micro Therapeutics, Inc. Announces Receipt of Exchange Offer Proposal From ev3 Inc.	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/10/06	03 : 04	PR Newswire (US)	Micro Therapeutics, Inc. Reports Sales Results for Third Quarter 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/08/03	06 : 51	PR Newswire (US)	Micro Therapeutics Reports 44% Increase in Net Sales for 2005 Second Quarter; Company Raises Sales Guidance for 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/08/03	06 : 48	PR Newswire (US)	ev3 Inc. Reports Second Quarter Financial Results	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/07/28	05 : 27	PR Newswire (US)	ev3 and Micro Therapeutics to Report 2005 Second Quarter Financial Results and Host Joint Conference Call on August 2, 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/07/22	07 : 27	PR Newswire (US)	ev3 Inc. Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/07/22	07 : 08	PR Newswire (US)	Micro Therapeutics Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/07/07	07 : 30	PR Newswire (US)	Micro Therapeutics, Inc. Reports Sales Results for Second Quarter 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/04/29	06 : 14	PR Newswire (US)	Micro Therapeutics Reports 50% Net Sales Increase for 2005 First Quarter	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/04/26	02 : 28	PR Newswire (US)	Micro Therapeutics to Report First Quarter Financial Results and Host Conference Call on April 28, 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/03/22	06 : 57	PR Newswire (US)	ev3 Announces Enrollment Has Begun for SpideRX(TM) Embolic Protection Device in Second Phase of Carotid Clinical Trial	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/02/11	05 : 23	PR Newswire (US)	Micro Therapeutics Reports Record Revenue in 2004 Fourth Quarter and Full Year Financial Results	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/02/10	21 : 45	PR Newswire (US)	Reminder - Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/02/08	08 : 40	PR Newswire (US)	Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 10, 2005	NASDAQ:MTIX	Micro Therapeutics (MM)
2005/02/01	21 : 00	PR Newswire (US)	Micro Therapeutics Receives $3.7 Million Payment	NASDAQ:MTIX	Micro Therapeutics (MM)
2004/12/30	02 : 13	PR Newswire (US)	Micro Therapeutics Consolidates Manufacturing Capabilities	NASDAQ:MTIX	Micro Therapeutics (MM)
2004/12/07	05 : 04	PR Newswire (US)	ev3 Receives Investigational Device Exemption for Use of SpideRX(TM) Embolic Protection Device in Clinical Trial	NASDAQ:MTIX	Micro Therapeutics (MM)
2004/11/10	23 : 00	PR Newswire (US)	ev3 International Files Lawsuit Against Distributors in Hong Kong and Phoenix	NASDAQ:MTIX	Micro Therapeutics (MM)
2004/11/04	21 : 00	PR Newswire (US)	Micro Therapeutics Reports 2004 Third Quarter Financial Results	NASDAQ:MTIX	Micro Therapeutics (MM)
2004/11/02	05 : 24	PR Newswire (US)	Micro Therapeutics to Report 2004 Third Quarter Financial Results and Host Conference Call on November 4	NASDAQ:MTIX	Micro Therapeutics (MM)
2004/10/22	00 : 47	PR Newswire (US)	FDA Grants Marketing Clearance to ev3 for Protege(R) GPS(TM) Long Stents	NASDAQ:MTIX	Micro Therapeutics (MM)
2004/09/21	22 : 01	PR Newswire (US)	ev3(TM) Receives 510(k) Marketing Clearance for X-SIZER(R) Thrombectomy Catheter System for Dialysis Graft Use	NASDAQ:MTIX	Micro Therapeutics (MM)
2004/08/27	01 : 33	PR Newswire (US)	ev3 Receives CE Mark Approval for Tapered Stents for Carotid Stenting Procedures	NASDAQ:MTIX	Micro Therapeutics (MM)
2004/08/19	02 : 51	PR Newswire (US)	Micro Therapeutics Completes Issuance of Common Stock for Exchangeable Notes	NASDAQ:MTIX	Micro Therapeutics (MM)